• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Fidelity Select Biotechnology Portfolio (FBIOX)

    222.33 Up 5.32(2.45%) Dec 26
    Prev Close:217.01
    YTD Return*:32.01%
    Net Assets*:10.45B
    Yield*:N/A

    * As of 30-Nov-14

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Top Holdings

    Symbol% AssetsYTD Return %
    GILD11.1336.07
    VRTX5.5860.09
    CELG5.3036.36
    ALXN4.3851.10
    REGN4.2053.04

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:10.45B
    Category:Health
    Annual Report Expense Ratio (net):0.75%

    Performance & Risk

    YTD Return:32.01%
    5y Avg Return:32.75%
    Rank in Category (ytd):13
    % Rank in Category (ytd):10.32%
    Beta (3y):0.79
    Morningstar Risk Rating:5

    Fund Summary

    The investment seeks capital appreciation. The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback